Growth Metrics

Merck (MRK) Cash & Current Investments (2016 - 2025)

Merck (MRK) has disclosed Cash & Current Investments for 17 consecutive years, with $14.6 billion as the latest value for Q4 2025.

  • Quarterly Cash & Current Investments rose 6.4% to $14.6 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $14.6 billion through Dec 2025, up 6.4% year-over-year, with the annual reading at $14.6 billion for FY2025, 6.4% up from the prior year.
  • Cash & Current Investments for Q4 2025 was $14.6 billion at Merck, down from $18.2 billion in the prior quarter.
  • The five-year high for Cash & Current Investments was $18.2 billion in Q3 2025, with the low at $5.6 billion in Q1 2024.
  • Average Cash & Current Investments over 5 years is $10.3 billion, with a median of $9.6 billion recorded in 2021.
  • The sharpest move saw Cash & Current Investments tumbled 46.23% in 2023, then surged 92.99% in 2024.
  • Over 5 years, Cash & Current Investments stood at $8.1 billion in 2021, then surged by 62.94% to $13.2 billion in 2022, then crashed by 46.23% to $7.1 billion in 2023, then surged by 92.99% to $13.7 billion in 2024, then increased by 6.4% to $14.6 billion in 2025.
  • According to Business Quant data, Cash & Current Investments over the past three periods came in at $14.6 billion, $18.2 billion, and $8.6 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.